These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32767710)

  • 21. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
    Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
    Roe A; Hillman J; Butts S; Smith M; Rader D; Playford M; Mehta NN; Dokras A
    J Clin Endocrinol Metab; 2014 May; 99(5):E841-7. PubMed ID: 24512495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of concentrated pomegranate juice on biomarkers of inflammation, oxidative stress, and sex hormones in overweight and obese women with polycystic ovary syndrome: A randomized controlled trial.
    Abedini M; Ramezani-Jolfaie N; Ghasemi-Tehrani H; Tarrahi MJ; Amani R
    Phytother Res; 2023 Jun; 37(6):2255-2261. PubMed ID: 36654481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.
    Dejager S; Pichard C; Giral P; Bruckert E; Federspield MC; Beucler I; Turpin G
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):455-62. PubMed ID: 11318780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial.
    Karimi E; Heshmati J; Shirzad N; Vesali S; Hosseinzadeh-Attar MJ; Moini A; Sepidarkish M
    Lipids Health Dis; 2020 Apr; 19(1):60. PubMed ID: 32248805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome.
    Butler AE; Moin ASM; Reiner Ž; Sathyapalan T; Jamialahmadi T; Sahebkar A; Atkin SL
    Front Endocrinol (Lausanne); 2023; 14():1117761. PubMed ID: 37181037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial.
    Esmaeilinezhad Z; Babajafari S; Sohrabi Z; Eskandari MH; Amooee S; Barati-Boldaji R
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):201-208. PubMed ID: 30538082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone.
    Legro RS; Azziz R; Ehrmann D; Fereshetian AG; O'Keefe M; Ghazzi MN
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5137-44. PubMed ID: 14602740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S; Scoccia B; Yalamanchi S; Mazzone T
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome.
    Blum MR; Popat RA; Nagy A; Cataldo NA; McLaughlin TL
    J Endocrinol Invest; 2021 Oct; 44(10):2123-2130. PubMed ID: 33687700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent and Additive Effects of Coenzyme Q10 and Vitamin E on Cardiometabolic Outcomes and Visceral Adiposity in Women With Polycystic Ovary Syndrome.
    Izadi A; Shirazi S; Taghizadeh S; Gargari BP
    Arch Med Res; 2019 Feb; 50(2):1-10. PubMed ID: 31349945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
    Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
    Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors.
    Rocha MP; Marcondes JA; Barcellos CR; Hayashida SA; Curi DD; da Fonseca ÂM; Bagnoli VR; Baracat EC
    Gynecol Endocrinol; 2011 Oct; 27(10):814-9. PubMed ID: 20807166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency.
    Rahimi-Ardabili H; Pourghassem Gargari B; Farzadi L
    J Endocrinol Invest; 2013 Jan; 36(1):28-32. PubMed ID: 22453059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome.
    Hong Y; Yang D; Liu W; Zhao X; Chen X; Li L
    J Biol Regul Homeost Agents; 2011; 25(3):365-74. PubMed ID: 22023761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.